Overview

Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management

Status:
Completed

Trial end date:
2018-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess safety and efficacy of Ticagrelor versus Clopidogrel in Asian/KOREAn patients with acute coronary syndromes intended for invasive management.

Phase:

Phase 4

Details

Lead Sponsor:

Seung-Jung Park

Collaborator:

CardioVascular Research Foundation, Korea

Treatments:

Clopidogrel
Ticagrelor
Ticlopidine